Identifying HER2 from serum‐derived exosomes in advanced gastric cancer as a promising biomarker for assessing tissue HER2 status and predicting the efficacy of trastuzumab‐based therapy

PURPOSE: This study aimed to evaluate the clinical relevance of exosomal HER2 (Exo HER2) level in assessing the tissue HER2 status and predicting the efficacy of trastuzumab treatment. METHODS: In this prospective study, patients with advanced gastric cancer (AGC) from three hospitals between August...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qian, Lv, Minzhi, Lv, Lihua, Cao, Nida, Zhao, Aiguang, Chen, Jiayan, Tang, Xi, Luo, Rongkui, Yu, Shan, Zhou, Yan, Cui, Yuehong, Guo, Wei, Liu, Tianshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972160/
https://www.ncbi.nlm.nih.gov/pubmed/36208025
http://dx.doi.org/10.1002/cam4.5269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972160/
https://www.ncbi.nlm.nih.gov/pubmed/36208025
http://dx.doi.org/10.1002/cam4.5269

Ejemplares similares